VR Logo

Gland Pharma Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

45 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

Get the Stocks!

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

Financial Year Full AR Chairman's
Speech		 Director's
Report		 Management
Discussion		 Corporate
Governance		 Auditor's
Report		 Notes to
Accounts
2020 download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes
2016 download pdf full AR download pdf chairman speech download pdf director's report download pdf management discussion download pdf corporate governance download pdf auditor's report download pdf account notes

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1978

Chairman: Yiu Kwan Stanley Lau

Managing Director: Srinivas Sadu

Group: --

Listing: NSE: GLAND, BSE: 543245

Headquarters: Hyderabad, Telangana

Website: www.glandpharma.com

Key Facts

Market cap: R 64,848.23 Cr

Revenue (TTM): R 2,633.24 Cr

Earnings (TTM): R 772.86 Cr

Cash: R 1,325.19 Cr

Total Debt: R 4.96 Cr

Promoters' ownership: 58.14%

Liquidity: High

52 Week range: R 1,700.00 - 4,180.00

Face value: R1.00

Shares outstanding: 16,42,37,173

10 Years Aggregate:

  • CFO: 2,392.72 Cr
  • EBITDA: 4,483.49 Cr
  • Net Profit: 3,052.78 Cr

Stock Performance

Time Period Gland Pharma S&P BSE Sensex S&P BSE Healthcare
YTD67.9910.1320.64
1 month14.780.202.22
3 months41.307.8011.16
1 Year--39.8343.05
3 Years--11.8222.57
5 Years--13.389.91
10 Years--11.1815.06
As on 30-Jul-2021